Flagship explainer
What drives Twist Bioscience Corporation’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$77.7M | FY2025 |
| |
| Income before tax | −$77M | FY2025 |
|
| Operating income | −$136M | FY2025 |
|
| $377M | FY2025 |
| |
| Ending assets | $642M | FY2025 |
|
| Beginning assets | $614M | FY2024 |
|
| $473M | FY2025 |
| |
| $473M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001581280-25-000025
- SEC filingFiling detailsAccession 0001628280-24-048262